Sort
17,828 grants matching “crispr”
Analyzing the mechanism of exosome mediated DNA Methyltransferase activity during sepsis
$97,323Jon R Wisler · Ohio State University · K08 · FY2023 · GM
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
$97,313Jonathan S. Weissman · University Of California, San Francisco · R01 · FY2017 · DA
Pancreatic cancer stem cells: PD2-mediated novel mechanistic link and metabolomic alterations
$97,077Saswati Karmakar · Stanford University · K00 · FY2024 · CA
CSDE1 as a Post Transcriptional Regulator of the LDLR - Diversity Supplement
$97,076John S Chorba · University Of California, San Francisco · R01 · FY2022 · HL
Mechanisms of Myotonic Dystrophy Type 2-causing CCTG DNA Repeat Instability
$97,050Jane C Kim · California State University San Marcos · SC3 · FY2020 · GM
Genomics, Genetics and Epigenetics Research Program
$97,007Lajos Pusztai · Yale University · P30 · FY2025 · CA
Molecular Genetics Core
$96,944Richard A Flavell · Yale University · P30 · FY2023 · DK
Molecular Genetics Core
$96,944Richard A Flavell · Yale University · P30 · FY2024 · DK
Molecular Genetics Core
$96,944Richard A Flavell · Yale University · P30 · FY2025 · DK
Hereditary Cancer Variants of Uncertain Significance in Stem Cells
$96,922Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · CA
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
$96,870Arupratan Das · Johns Hopkins University · K99 · FY2017 · EY
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
$96,781Arupratan Das · Johns Hopkins University · K99 · FY2018 · EY
Predicting the functional impact of non-coding mutations using patient-specific gene regulatory networks
$96,691Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Expanding pharmacological modalities for targeted cancer therapy
$96,632Hojong Yoon · Broad Institute, Inc. · K00 · FY2022 · CA
Manipulation of three-dimensional chromatin structure to regulate oncogenes in breast and ovarian cancer.
$96,563Stefanie L Morgan · Massachusetts General Hospital · K00 · FY2020 · CA
Reprogramming Metabolic Networks in the Tumor Microenvironment
$96,552Samuel Andrew Kerk · Salk Institute For Biological Studies · K00 · FY2025 · CA
Amplifications and signaling of oncoproteins in cancer
$96,120King L. Hung · Scripps Research Institute, The · K00 · FY2025 · CA
Understanding double-stranded RNA recognition in human cells
$96,110Wenwen Fang · Univ Of Massachusetts Med Sch Worcester · R35 · FY2024 · GM
Understanding chromatin modulation of copy number and rereplication
$95,994Johnathan R. Whetstine · Massachusetts General Hospital · R01 · FY2019 · GM
A visible machine learning system to discover targeted treatment solutions in cancer
$95,948Yue Qin · Broad Institute, Inc. · K00 · FY2024 · CA
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$95,776Aaron D. Gitler · Stanford University · R35 · FY2019 · NS
Uncovering cell-intrinsic restrictions to CRISPR-Cas9 gene editing
$95,731Jennifer R Hamilton · University Of California Berkeley · K99 · FY2022 · GM
RESEARCH PROJECT 2
$95,687Jeffery S Cox · University Of California, San Francisco · U19 · FY2021 · AI
Identifying Metabolic Vulnerabilities in Pancreatic Cancer
$95,669Douglas Biancur · New York University School Of Medicine · K00 · FY2022 · CA
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
$95,644Mitchell O'Connell · University Of Rochester · R35 · FY2021 · GM